Cancer Site | FN (n = 1524) | AOM (n = 36,552) | p value |
---|---|---|---|
Bladder | 13 (0.9%) | 814 (2.2%) | 0.0003 |
Breast | 210 (13.8%) | 5219 (14.3%) | 0.5853 |
Cervix | 43 (3.0%) | 286 (0.8%) | < 0.0001 |
Chronic Lymphocytic Leukemia | 7 (0.5%) | 351 (1.8%) | 0.0001 |
Colorectal | 240 (15.7%) | 5063 (13.9%) | 0.0362 |
Kidney | 136 (8.9%) | 1177 (3.2%) | < 0.0001 |
Lung & Bronchus | 205 (13.5%) | 5306 (14.5%) | 0.247 |
Melanoma | 8 (0.5%) | 988 (2.7%) | < 0.0001 |
Non-Hodgkin Lymphoma | 65 (4.6%) | 1609 (4.4%) | 0.7985 |
Ovarian | 32 (2.1%) | 545 (1.5%) | 0.0567 |
Pancreas | 32 (2.1%) | 914 (2.5%) | 0.3247 |
Prostate | 134 (8.8%) | 4558 (12.5%) | < 0.0001 |
Stomach | 29 (1.9%) | 727 (2.0%) | 0.8135 |
Thyroid | 20 (1.3%) | 667 (1.8%) | 0.1409 |
Uterine | 38 (2.5%) | 1263 (3.5%) | 0.0428 |
Other | 355 (23.3%) | 7051 (19.3%) | 0.0714 |